FOXN3-AS1: A Candidate Prognostic Marker and Epigenetic Target with Immunotherapeutic Implications in Acute Myeloid Leukemia.
Current medicinal chemistry
View this publicationCurrent medicinal chemistry
View this publicationBMC pulmonary medicine
View this publicationInsights into imaging
View this publicationImmunity
View this publicationRSC chemical biology
View this publicationThe European respiratory journal
View this publicationCell reports
View this publicationEuropean radiology experimental
View this publicationTranslational psychiatry
View this publicationiScience
View this publication